UPDATE: Reata Pharmaceuticals (RETA) PT Raised to $93 at Goldman Sachs
Tweet Send to a Friend
(Updated - May 10, 2022 11:30 AM EDT)
Goldman Sachs analyst Madhu Kumar raised the price target on Reata ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar raised the price target on Reata ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
